Overview
Status
Active
Registry date
2025-02-12
Share capital
100,000.00 PLN
Registered address
ul. Leśna 8, 22-150 Wierzbica-Osiedle, Poland
Industry
Authorized Representatives
Sławomir Paweł Chmielarczykage 54 – President of the Management Board
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 99 | $26,742.30 | 99% | |
Others | 1 | $270.12 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aldemed Centrum Medycznesp. z o.o. | $17,163,375.93 | aldemed.pl | ||
| Centrum Medyczne Internussp. z o.o. | $10,850,327.50 | internus.pl | ||
| Bełchatowskie Centrum Medyczne Niepubliczny Zakład Opieki Zdrowotnejsp. z o.o. | $3,765,211.52 | bcm-belchatow.pl | ||
| Centermed Poznańsp. z o.o. | $3,656,726.26 | centermed.pl | ||
| ALTEsp. z o.o. | $1,796,193.63 | nova.chojnice.pl | ||
| Mmedicalsp. z o.o. | $947,800.06 | mmedical.pl | ||
| Osasuna Bellesasp. z o.o. | $594,032.53 | kobylka.osasuna.pl | ||
| Fundacja Abdomed Całodobowa Pomoc MedycznaS.K.A. | $310,409.00 | abdomed.pl | ||
| Novamed24sp. z o.o. | $75,654.70 | novamed24.pl | ||
| Plus-Medicsp. z o.o. | – | plusmedic.pl |
FAQ
The main business activity of Zdrovita Ms focuses on general medical practice activities.
The company was registered in the Polish National Court Register (KRS) on February 12, 2025.
The headquarters is located at: ul. Leśna 8, 22-150 Wierzbica-Osiedle.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from February 12, 2025 to December 31, 2025.
Last updated: 2026-08-09